Check patentability & draft patents in minutes with Patsnap Eureka AI!

A Chrysin Leucine Derivative with EGFR Kinase Inhibitory Activity

A leucine methyl ester and drug technology, applied in organic active ingredients, medical preparations containing active ingredients, organic chemistry, etc., can solve the problems of undisclosed and undisclosed EGFR tyrosine kinase targeted inhibition

Active Publication Date: 2020-10-23
NANHUA UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In summary, although chrysin modified by amino acid structure has been reported in the literature, these compounds only provide inhibitory activity on some cancer cells, but have not disclosed their targeted inhibitory effect on EGFR tyrosine kinase. It is also not disclosed that the modified compound can specifically block the division of cancer cells so as to cause the death of cancer cells, so that it has no killing activity on normal human cells while killing cancer cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A Chrysin Leucine Derivative with EGFR Kinase Inhibitory Activity
  • A Chrysin Leucine Derivative with EGFR Kinase Inhibitory Activity
  • A Chrysin Leucine Derivative with EGFR Kinase Inhibitory Activity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] N- [2-(5-Hydroxy-2-phenyl- 4H -Benzopyrone-7-O)octanoyl]-L-leucine methyl ester (Compound I)

[0038]

[0039] Step 1: Add anhydrous potassium carbonate (2073.2 mg) to a solution of chrysin (2524.4 mg) in acetone (100 mL) with stirring. Stir at 60°C for 30 min. Ethyl 2-bromooctanoate (2724 μL) and the catalyst potassium iodide (166.0 mg) were slowly added dropwise with a constant pressure dropping funnel, and the mixture was stirred and refluxed at 60°C. After the reaction was detected by TLC, it was cooled, filtered, and the filter residue was washed with a small amount of acetone, and the organic solvent was removed from the obtained filtrate on a rotary evaporator. After separation and purification by silica gel column chromatography (dichloromethane / acetone=50:1), compound 3 was obtained. Yield: 60%. m.p.100-103°C. 1 H NMR (500 MHz, CDCl 3 ) δ 12.69 (d, J = 22.9 Hz, 1H), 7.85 (t, J = 10.7 Hz, 2H),7.62 – 7.41 (m, 3H), 6.66 (s, 1H), 6.47 (d, J = 1.9 Hz...

Embodiment 2

[0046] Example 2 In vitro activity test

[0047] The cell lines are MCF-7 (human breast cancer cells) and HVECs (human normal vascular endothelial cells).

[0048] The culture medium is DMEM+10% FBS+ 5 mL double antibody

[0049] Sample solution preparation: After dissolving with DMSO (Merck), the concentration is 33333.33 μmol / L

[0050] 1. Seed the plate Add the cell suspension to a 96-well plate, 100 μL per well (the cell content in each well is about 8000 cells / well), store at 37°C, 5% CO 2 Cultivate in the incubator for 24 h;

[0051] 2. Add drug-use medium to prepare the gradient concentration of the sample solution (256, 128, 64, 32, 16, 8, 4, 2 μmol / L), discard the original medium on the 96-well plate, and add different concentrations of drugs to culture base, 100 μL per well, and 5 auxiliary wells for each concentration. For the remaining wells, use the medium containing 3‰ DMSO as a control, and incubate in a 5% incubator at 37°C for 48 h;

[0052] 3. MTT method...

Embodiment 3

[0055] Example 3 Effects of compounds on colony formation and migration of cancer cells MCF-7 (human breast cancer cells) was selected as the cell line

[0056] 1. Mark the culture plate on the back of the 6-well plate with a marker, and use a ruler to draw a line along the diameter of the well to divide each well into 2 parts.

[0057] 2. Add a certain amount of cells to the wells, because different cells grow at different speeds, and the amount of cells taken is also different. The principle of inoculation is that the cells in the wells are basically covered with no obvious gaps after overnight.

[0058] 3. Cell streaking Use a 200 μL sterile tip perpendicular to the cell plane, and scratch the cell layer along the ruler.

[0059] 4. Wash the cells with PBS and take pictures to observe the scratches. After the scratches are completed, wash the cells with PBS 3 times to wash away the non-adherent cells, that is, the cells that were streaked when streaking. Make the gaps lef...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a chrysin leucine derivative with EGFR kinase inhibiting activity. The chrysin leucine derivative is capable of specifically blocking cancer cell division to kill cancer cellswithout killing activity on human normal cells, so that side effects resulted from killing of the human normal cells can be effectively avoided. Therefore, the chrysin leucine derivative can serve asan active component of antitumor medicines and has a promising development and application prospect.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a chrysin leucine derivative with EGFR kinase inhibitory activity, its preparation method and its application. Background technique [0002] Cancer has a high morbidity rate and high mortality rate. It is one of the diseases that seriously threaten human health. According to the statistics of the World Health Organization, there were more than 14 million new cancer patients in the world in 2012, and more than 8.2 million cancer deaths. Chemotherapy is currently one of the most effective ways to treat cancer. Traditional chemotherapy drugs non-specifically block cell division and cause cell death. While killing cancer cells, they also destroy the growth of normal human cells, causing many toxic and side effects. In recent years, with the development of the global life science field, the process of cancer invasion and metastasis is gradually being elucidated. Nowadays, there ar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D311/30A61K31/352A61P35/00
Inventor 刘运美李洋何军张奇志
Owner NANHUA UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More